CENTOFANTI, LUCIA
CENTOFANTI, LUCIA
Dipartimento di Scienze della Salute
Reply to the letter comment of Su Boon Yong MD, PhD and colleagues to: Improved glycemic and weight control with Dulaglutide addition in SGLT2 inhibitor treated obese type 2 diabetic patients at high cardiovascular risk in a real-world setting. The AWARE− 2 study
2025 C. Berra, R. Manfrini, F. Bifari, E. Cipponeri, R. Ghelardi, L. Centofanti, U. Mortola, E. Lunati, L. Bucciarelli, V. Cimino, F. Folli
Continuous interstitial glucose monitoring in diabetic and non-diabetic critically ill patients is simple and accurate: comparison with venous, arterial and capillary glucose measurements
2025 D. Chiumello, M. Passeri, S. Coppola, E. Chiodaroli, S. Carnier, M. Montante, T. Pozzi, I. Goggi, F. Bifari, U. Mortola, L. Centofanti, F. Folli
Analysis of morbid obese diabetic and non-diabetic patients: clinical and social characteristics, habits and workup to undergo bariatric surgery in Lombardy, Italy
2025 A.E. Pontiroli, S. Guarino, M. Tagliabue, L. La Sala, L. Centofanti, S. Olmi, G. Sarro, A. Giovanelli, C. Asteria, E. Galfrascoli, U. Mortola, L. Bucciarelli, M.A. Zappa, E. Tagliabue, F. Folli
Unraveling neuroinflammation: Sphingolipids as key mediators of inflammatory responses in activated microglia
2024 S. Penati, L. Montavoci, S. Casati, M. Trinchera, L. Centofanti, A. Caretti, M. Dei Cas
The Relationship of Glucose Intolerance/Diabetes and Overweight/Obesity with Sphingolipidoma Alterations
2024 C. Morano, L. Centofanti, M.V. DEI CAS, S. Penati, E. Bianco, M. Bignotto, C. Berra, P. Zermiani, R. Paroni, P.M. Battezzati, F. Folli
Effects of Melatonin on Exercise-Induced Oxidative Stress in Adults with Obesity Undergoing a Multidisciplinary Body Weight Reduction Program
2024 A.E. Rigamonti, F.M. Rubino, D. Caroli, A. Bondesan, S. Mai, S.G. Cella, L. Centofanti, R. Paroni, A. Sartorio
The triglyceride-glucose index, blood glucose levels, and metabolic syndrome are associated with all-cause mortality in obesity
2024 A.E. Pontiroli, L. Centofanti, A.S. Zakaria, S. Cerutti, M. Dei Cas, R. Paroni, L. La Sala, E. Tagliabue, S. Magnani, F. Folli
Glucagon-like peptide 1 receptor is a T cell-negative costimulatory molecule
2024 M. Ben Nasr, V. Usuelli, S. Dellepiane, A.J. Seelam, T.V. Fiorentino, F. D'Addio, E. Fiorina, C. Xu, Y. Xie, H.B. Balasubramanian, E. Castillo-Leon, L. Loreggian, A. Maestroni, E. Assi, C. Loretelli, A. Abdelsalam, B. El Essawy, S. Uccella, I. Pastore, M.E. Lunati, G. Sabiu, A. Petrazzuolo, G. Ducci, E. Sacco, L. Centofanti, M. Venturini, S. Mazzucchelli, D. Mattinzoli, M. Ikehata, G. Castellano, G. Visner, L. Kaifeng, K.M. Lee, Z. Wang, D. Corradi, S. La Rosa, S. Danese, J. Yang, J.F. Markmann, G.V. Zuccotti, R. Abdi, F. Folli, P. Fiorina
Investigating the Impact of Epstein-Barr Virus on Sphingolipid Composition in Extracellular Vesicles of Multiple Sclerosis Patients
2024 L. Centofanti, A. Zollo, M. Dei Cas, V. Citro, D. Giannandrea, E. Soleymaninejadian, A. Mingione, A. Corona, A. Priori, M. Miozzo, F. Folli, R. Paroni, R. Chiaramonte, F. Martinelli Boneschi
Synergistic effects of glucose tolerance and BMI on cardiovascular events and all-cause mortality in a healthy population. CA.ME.LI.A study 7 year follow-up
2024 M. Bignotto, E. Bianco, L. Centofanti, A. Russo, M. Dei Cas, P. Zermiani, C. Morano, F. Samartin, E. Bertolini, F. Bifari, C. Berra, M. Zuin, R. Paroni, P.M. Battezzati, F. Folli
Improved glycemic and weight control with Dulaglutide addition in SGLT2 inhibitor treated obese type 2 diabetic patients at high cardiovascular risk in a real-world setting. The AWARE-2 study
2024 C. Berra, R. Manfrini, F. Bifari, E. Cipponeri, R. Ghelardi, L. Centofanti, U. Mortola, E. Lunati, L. Bucciarelli, V. Cimino, F. Folli
Mechanisms of action of incretin receptor based dual- and tri-agonists in pancreatic islets
2023 F. Folli, G. Finzi, R. Manfrini, A. Galli, F. Casiraghi, L. Centofanti, C. Berra, P. Fiorina, A. Davalli, S. La Rosa, C. Perego, P.B. Higgins
Obesity effect on newly diagnosed and recurrent post-ablation atrial fibrillation: a systematic review and meta-analysis
2023 F. Folli, L. Centofanti, S. Magnani, E. Tagliabue, M. Bignotto, L. La Sala, A.E. Pontiroli
Alanine transferase levels (ALT) and triglyceride-glucose index are risk factors for type 2 diabetes mellitus in obese patients
2023 F. Folli, A.E. Pontiroli, A.S. Zakaria, L. Centofanti, E. Tagliabue, L. La Sala